Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Nov;30(11):2793–2796. doi: 10.1128/jcm.30.11.2793-2796.1992

Evaluation of three immunoassays for detection of Chlamydia trachomatis in urine specimens from asymptomatic males.

G P Leonardi 1, M Seitz 1, R Edstrom 1, J Cruz 1, P Costello 1, K Szabo 1
PMCID: PMC270530  PMID: 1452648

Abstract

The performances of three commercially available immunoassays (Chlamydiazyme/Antibody Blocking Assay [Abbott Diagnostics, Abbott Park, Ill.], IDEIA [Analytab Products, Plainview, N.Y.], and Microtrak EIA [Syva Co. Palo Alto, Calif.]) were evaluated for the detection of Chlamydia trachomatis in urine specimens from asymptomatic males. Assay results were compared with direct specimen immunofluorescence (DFA) analysis of urine sediment (Syva Microtrak; Syva Co.), which was chosen as the study confirmation assay. An overall Chlamydia prevalence of 7% (24 of 340) was found in our study population, with peak incidences occurring in the adolescent (8 of 93 specimens) and young adult (11 of 146 specimens) age groups. Sensitivity and specificity data among the Chlamydiazyme, IDEIA, and Microtrak enzyme immunoassays (EIAs) were determined to be 79.1 and 99%, 91.7 and 98%, and 95.8 and 99%, respectively. The Microtrak EIA and IDEIA products demonstrated sensitivities and specificities equal to or greater than those claimed for urine specimens. The diagnostic accuracies of these assays on asymptomatic subjects, along with the ease of this collection method, suggest a role for these products as screening tools. The sensitivity of the Chlamydiazyme assay was lower than that claimed previously in symptomatic patients, with 5 of 24 positive specimens demonstrating false-negative results. In those cases, centrifugation of the original immunoassay aliquot material and then DFA examination confirmed specimen positivity. Urine immunoassay screening in combination with DFA confirmation (which was chosen because it has antibody epitopic specificity different from that of the primary assay) provides a high degree of diagnostic precision. The use of noninvasive collection methods could result in greater testing compliance among asymptomatic males and, subsequently, could reduce the incidences of both symptomatic and silent chlamydial infections.

Full text

PDF
2793

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Boyd R. S., DeMaio J. Use of Chlamydiazyme on urine sediment for diagnosis of Chlamydia trachomatis genital infections. Mil Med. 1991 Aug;156(8):420–421. [PubMed] [Google Scholar]
  2. Brady M., Baker C., Neinstein L. S. Asymptomatic Chlamydia trachomatis infections in teenage males. J Adolesc Health Care. 1988 Jan;9(1):72–75. doi: 10.1016/0197-0070(88)90022-8. [DOI] [PubMed] [Google Scholar]
  3. Braverman P. K., Biro F. M., Brunner R. L., Gilchrist M. J., Rauh J. L. Screening asymptomatic adolescent males for chlamydia. J Adolesc Health Care. 1990 Mar;11(2):141–144. doi: 10.1016/0197-0070(90)90024-v. [DOI] [PubMed] [Google Scholar]
  4. Chernesky M., Castriciano S., Sellors J., Stewart I., Cunningham I., Landis S., Seidelman W., Grant L., Devlin C., Mahony J. Detection of Chlamydia trachomatis antigens in urine as an alternative to swabs and cultures. J Infect Dis. 1990 Jan;161(1):124–126. doi: 10.1093/infdis/161.1.124. [DOI] [PubMed] [Google Scholar]
  5. Fisher M., Swenson P. D., Risucci D., Kaplan M. H. Chlamydia trachomatis in suburban adolescents. J Pediatr. 1987 Oct;111(4):617–620. doi: 10.1016/s0022-3476(87)80134-8. [DOI] [PubMed] [Google Scholar]
  6. Moncada J., Schachter J., Bolan G., Engelman J., Howard L., Mushahwar I., Ridgway G., Mumtaz G., Stamm W., Clark A. Confirmatory assay increases specificity of the chlamydiazyme test for Chlamydia trachomatis infection of the cervix. J Clin Microbiol. 1990 Aug;28(8):1770–1773. doi: 10.1128/jcm.28.8.1770-1773.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. O'Brien S. F., Bell T. A., Farrow J. A. Use of a leukocyte esterase dipstick to detect Chlamydia trachomatis and Neisseria gonorrhoeae urethritis in asymptomatic adolescent male detainees. Am J Public Health. 1988 Dec;78(12):1583–1584. doi: 10.2105/ajph.78.12.1583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Paul I. D., Caul E. O. Evaluation of three Chlamydia trachomatis immunoassays with an unbiased, noninvasive clinical sample. J Clin Microbiol. 1990 Feb;28(2):220–222. doi: 10.1128/jcm.28.2.220-222.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Rice P. A., Schachter J. Pathogenesis of pelvic inflammatory disease. What are the questions? JAMA. 1991 Nov 13;266(18):2587–2593. [PubMed] [Google Scholar]
  10. Schachter J. Why we need a program for the control of Chlamydia trachomatis. N Engl J Med. 1989 Mar 23;320(12):802–804. doi: 10.1056/NEJM198903233201210. [DOI] [PubMed] [Google Scholar]
  11. Schwebke J. R., Clark A. M., Pettinger M. B., Nsubga P., Stamm W. E. Use of a urine enzyme immunoassay as a diagnostic tool for Chlamydia trachomatis urethritis in men. J Clin Microbiol. 1991 Nov;29(11):2446–2449. doi: 10.1128/jcm.29.11.2446-2449.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Schwebke J. R., Stamm W. E., Handsfield H. H. Use of sequential enzyme immunoassay and direct fluorescent antibody tests for detection of Chlamydia trachomatis infections in women. J Clin Microbiol. 1990 Nov;28(11):2473–2476. doi: 10.1128/jcm.28.11.2473-2476.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Sellors J., Mahony J., Jang D., Pickard L., Castriciano S., Landis S., Stewart I., Seidelman W., Cunningham I., Chernesky M. Rapid, on-site diagnosis of chlamydial urethritis in men by detection of antigens in urethral swabs and urine. J Clin Microbiol. 1991 Feb;29(2):407–409. doi: 10.1128/jcm.29.2.407-409.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Shafer M. A., Schachter J., Moscicki A. B., Weiss A., Shalwitz J., Vaughan E., Millstein S. G. Urinary leukocyte esterase screening test for asymptomatic chlamydial and gonococcal infections in males. JAMA. 1989 Nov 10;262(18):2562–2566. [PubMed] [Google Scholar]
  15. Werner M. J., Biro F. M. Urinary leukocyte esterase screening for asymptomatic sexually transmitted disease in adolescent males. J Adolesc Health. 1991 Jun;12(4):326–328. doi: 10.1016/0197-0070(91)90008-a. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES